All In Biotech

Drug Trial Radar · NCT04898283

Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.

Prospective, Multicentre, Doubleblind, Placebo-controlled RCT to Evaluate Efficacy and Safety With SC Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma Sensitised to Grasses and Cupressaceae

Last checked: Nov 20, 2026Latest source record: May 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

May 31, 2021

Primary completion

Oct 2026

Study completion Oct 2026

Sponsor

Lead sponsor
Inmunotek S.L.Industry
Sponsor type
Industry
First posted
May 24, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Randomized, Double-Blinded, Placebo-Controlled, Prospective, Multicenter Clinical Trial to Evaluate the Efficacy and Safety of Subcutaneous Immunotherapy in Patients With Rhinitis/Rhinoconjunctivitis With or Without Mild to Moderate Asthma Sensitized to cupressaceae and grasses.

Conditions

  • Rhinitis, Allergic
  • Rhinoconjunctivitis
  • Asthma, Allergic

Interventions

  • 10,000 MG01 +10,000 T521Biological

    Purified and polymerized with glutaraldehyde allergen extract, from a mixture of grasses (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca pratensis, Lolium perenne and Dactylis glomerata) and cupressaceae (Juniperus oxycedrus), adsorbed on aluminum hydroxide. The other ingredients are: sodium chloride (0.9%), phenol (0.4%) and water for injections

  • 30,000 MG01 +10,000 T521Biological

    Purified allergen extract polymerized with glutaraldehyde, from a mixture of grasses (Phleum pratense, Holcus lanatus, Poa pratensis, Festuca pratensis, Lolium perenne and Dactylis glomerata) and cupressaceae (Juniperus oxycedrus), adsorbed on aluminum hydroxide. The other ingredients are: sodium chloride (0.9%), phenol (0.4%) and water for injections.

  • Placebo subcutaneousOther

    The same solution and presentation as the active treatment, but without active ingredients

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. RCSMS: Combined Symptoms and Medication Score of rhinitis. Combined symptom and medication score in rhinitis/rhinoconjunctivitis (RCSMS)Time frame: 18 months

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital Nuestra Señora de Sonsoles

    Ávila, Spain · Not yet recruiting

  • Fundación Hospital Sant Pere Claver

    Barcelona, Spain · Withdrawn

  • Clínica privada Burgos

    Burgos, Spain · Withdrawn

  • Hospital Universitario de Burgos

    Burgos, Spain · Recruiting

  • Hospital General de Villalba

    Collado Villalba, Spain · Not yet recruiting

  • Clinica privada

    León, Spain · Withdrawn

  • Clínica Subiza

    Madrid, Spain · Active not recruiting

  • Hospital Carlos III (antiguo CAP José Marva)

    Madrid, Spain · Withdrawn

  • Clínica Privada

    Madrid, Spain · Withdrawn

  • Hospital Universitario Ramón y Cajal

    Madrid, Spain · Not yet recruiting

  • Hospital Universitario Fundación Jiménez Díaz

    Madrid, Spain · Recruiting

  • Hospital Infanta Elena

    Madrid, Spain · Not yet recruiting

  • Centro médico Saluddia

    Madrid, Spain · Recruiting

  • Centro Médico Iza (Clínica Privada Madrid)

    Madrid, Spain · Recruiting

  • Consulta Privada

    Palencia, Spain · Completed

  • Hospital Clínico de Salamanca

    Salamanca, Spain · Active not recruiting

  • Hospital General Universitario de Segovia

    Segovia, Spain · Not yet recruiting

  • Clinica Privada Soria

    Soria, Spain · Withdrawn

  • Clínica Privada

    Zaragoza, Spain · Withdrawn

  • Hospital Recoletas Felipe Ii

    Valladolid, Castille and León, Spain · Recruiting

  • Cedt de Tarancón

    Tarancón, Cuenca, Spain · Recruiting

  • Hospital Universitario Principe de Asturias

    Alcalá de Henares, Madrid, Spain · Completed

  • Hospital U. Fundación Alcorcón

    Alcorcón, Madrid, Spain · Recruiting

  • Hospital Cruz Roja Madrid

    Madrid, Madrid, Spain · Recruiting

  • Clínica Privada Dres Ojeda

    Madrid, Madrid, Spain · Recruiting

  • Hospital Universitario Puerta de Hierro

    Majadahonda, Madrid, Spain · Not yet recruiting

  • Clínica Privada Murcia

    Murcia, Murcia, Spain · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.